Your browser doesn't support javascript.
loading
Application of Value Framework to Phase III Trials of Immune Checkpoint Inhibitors in Esophageal and Gastric Cancer.
Thawani, Rajat; Agrawal, Neha; Taflin, Nicholas F; Kardosh, Adel; Chen, Emerson Y.
Afiliación
  • Thawani R; Knight Cancer Institute, Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Agrawal N; Department of Medicine, Oregon Health & Science University, Portland, OR 97239, USA.
  • Taflin NF; Department of Medicine, Oregon Health & Science University, Portland, OR 97239, USA.
  • Kardosh A; Knight Cancer Institute, Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Chen EY; Knight Cancer Institute, Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR 97239, USA.
Oncologist ; 28(1): 40-47, 2023 01 18.
Article en En | MEDLINE | ID: mdl-36130326
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article